{{Rsnum
|rsid=17641529
|Gene=KCTD8
|Chromosome=4
|position=44210148
|Orientation=plus
|GMAF=0.2479
|Gene_s=KCTD8
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 60.0 | 33.8 | 6.2
| HCB | 50.0 | 43.2 | 6.8
| JPT | 40.0 | 48.9 | 11.1
| YRI | 58.7 | 23.8 | 17.5
| ASW | 0.0 | 0.0 | 0.0
| CHB | 50.0 | 43.2 | 6.8
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22952603
  |Trait=Response to amphetamines
  |Title=Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).
  |RiskAllele=
  |Pval=9E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}